Souhaitez-vous accéder aux communiqués récents ?

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

CARMEL, Ind., July 28, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...

Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy

Gentherm acquires Innovative Medical Equipment, adding ThermaZone thermal therapy technology to expand its medical portfolio and growth opportunities.

Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.This report provides a comprehensive...

U.S. Commercial launch of Gen 2 Monarch System commencing today, July 21, 2026Gen 2 Monarch device provides an enhanced patient experience while delivering clinically proven therapeutic stimulation of...

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Consortium involving Sonus Microsystems wins ARPA-H MOCS award to develop wearable ultrasound for autonomous placental assessment.

AMT Medical publishes SAFE-CAB II in JTCVS: ELANA clip replaces hand-sewn bypass, delivering a strong safety profile and 92.5% graft patency at six months.

BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026,...